title: Adjuvant, neoadjuvant, and experimental regimens in overcoming pancreatic ductal adenocarcinoma.
abstract: Pancreatic cancer is one of the most aggressive and deadly malignancies. Despite better understanding of its biology and pathogenesis, contemporary treatment regimens are still insufficient. Along with the introduction of new treatment agents and combination therapy, the response rates are increasing, but these scores do not go with overall survival, and results are frequently conflicting. Therefore, contemporary medicine faces the challenge of expanding the knowledge base and practice on all grounds - pathology, factor risk, diagnosis, and finally surgical and palliative treatment of this disease. This paper provides a review of current adjuvant and neoadjuvant regimens and the role of experimental therapies in pancreatic ductal adenocarcinoma.
authors.affiliation: Department of Medical Biochemistry, Wroclaw Medical University, Wroclaw, Poland.
authors.forename: Olga
authors.initials: O
authors.lastname: Wysocka
authors.affiliation: Department of Medical Biochemistry, Wroclaw Medical University, Wroclaw, Poland.
authors.forename: Julita
authors.initials: J
authors.lastname: Kulbacka
authors.affiliation: Department of Medical Biochemistry, Wroclaw Medical University, Wroclaw, Poland.
authors.forename: Jolanta
authors.initials: J
authors.lastname: Saczko
keywords: epidemiology; pancreatic cancer; treatment